Scinai Immunotherapeutics Ltd. SCNI
NASDAQ
Recommendation
Dividend Power Score
Day's Range
$0.52$0.57
Latest Close
Volume
--
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
EPS (TTM)
| 06/30/2026 | 12/31/2025 | 06/30/2025 | |||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 168.35% | -15.43% | -67.85% | ||
| Total Receivables | -46.76% | -22.58% | 16.81% | ||
| Inventory | -- | -- | -- | ||
| Prepaid Expenses | 137.71% | -5.06% | -27.16% | ||
| Finance Division Loans and Leases Current | -- | -- | -- | ||
| Total Finance Division Other Current Assets | -- | -- | -- | ||
| Other Current Assets | 40.14% | 14.50% | 2.90% | ||
| Total Current Assets | 131.61% | -14.09% | -58.82% | ||
|
|
|||||
| Total Current Assets | 131.61% | -14.09% | -58.82% | ||
| Net Property, Plant & Equipment | 32.45% | -13.43% | -7.68% | ||
| Long-term Investments | -- | -- | -- | ||
| Goodwill | -- | -- | -- | ||
| Total Other Intangibles | -- | -- | -- | ||
| Finance Div Loans & Leases LT | -- | -- | -- | ||
| Total Finance Div Other LT Assets | -- | -- | -- | ||
| Total Other Assets | -- | -- | -- | ||
| Total Assets | 45.06% | -13.55% | -20.27% | ||
|
|
|||||
| Total Accounts Payable | 28.07% | 8.24% | 0.15% | ||
| Total Accrued Expenses | -- | -2.82% | -- | ||
| Short-term Debt | -- | -- | -- | ||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | ||
| Finance Division Debt Current | -25.75% | -22.41% | 36.54% | ||
| Total Finance Division Other Current Liabilities | 5.71% | -60.00% | 48.31% | ||
| Total Other Current Liabilities | 5.71% | -60.00% | 48.31% | ||
| Total Current Liabilities | 5.28% | -12.24% | 26.79% | ||
|
|
|||||
| Total Current Liabilities | 5.28% | -12.24% | 26.79% | ||
| Long-Term Debt | -2.73% | 13.08% | -98.52% | ||
| Short-term Debt | -- | -- | -- | ||
| Capital Leases | 86.85% | 17.26% | 144.69% | ||
| Finance Division Debt Non Current | -- | -- | -- | ||
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | ||
| Total Other Liabilities | -- | -- | 0.00% | ||
| Total Liabilities | 36.69% | 1.50% | -82.01% | ||
|
|
|||||
| Common Stock & APIC | 5.47% | 5.20% | 3.61% | ||
| Retained Earnings | -2.14% | -7.07% | 4.06% | ||
| Treasury Stock & Other | -22.93% | 0.00% | 0.00% | ||
| Total Common Equity | 173.64% | -43.08% | 130.63% | ||
|
|
|||||
| Preferred Stock Redeemable | 0.00% | 0.00% | -- | ||
| Preferred Stock Non Redeemable | -- | -- | -- | ||
| Preferred Stock Convertible | -- | -- | -- | ||
| Preferred Stock, Others | -- | -- | -- | ||
| Total Preferred Equity | 0.00% | 0.00% | -- | ||
|
|
|||||
| Total Common Equity | 173.64% | -43.08% | 130.63% | ||
| Total Preferred Equity | 0.00% | 0.00% | -- | ||
| Total Minority Interest | -- | -- | -- | ||
| Total Equity | 49.30% | -18.78% | 207.88% | ||
|
|
|||||